Company / Revenue
Labcorp Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$14.0B
FY2025
5-year range
$11.9B / $14.0B
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
#22 of 156
Health Care
What the data says
Labcorp's revenue of $14.0B is higher than 86% of companies in the Health Care sector (FY2025). Revenue has increased for 3 consecutive years, from $11.9B in FY2022 to $14.0B in FY2025.
Based on SEC 10-K filings.
$14.0B in FY2025 with a 5-year CAGR of +4.2%. Top quartile in the Health Care sector.
Improved from $12.2B to $14.0B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +5.6%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 156This company $14.0B Sector average $19.0B
▼
-26.6% below sector average
Key checks
Key Insights
- Labcorp's revenue has grown for 3 consecutive years.
- 5-year CAGR of +4.2%, indicating consistent growth.
- In FY2025, revenue increased 7.2% year-over-year.
- Ranks #22 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.0B | +7.2% |
| FY2024 | $13.0B | +7.0% |
| FY2023 | $12.2B | +2.5% |
| FY2022 | $11.9B | -9.7% |
| FY2021 | $13.1B | +15.9% |
| FY2020 | $11.3B | -1.9% |
| FY2019 | $11.6B | +2.0% |
| FY2018 | $11.3B | +9.9% |
| FY2017 | $10.3B | +7.9% |
| FY2016 | $9.6B | +10.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026